Autor: |
Kazemi, Farid, Azar, Mazyar, Kazemi, Foad, Hadisinia, Tahereh, Teymori, Javad, Geraily, Ghazale |
Zdroj: |
Reports of Practical Oncology & Radiotherapy; 2021, Vol. 26 Issue 6, p915-919, 5p |
Abstrakt: |
Background: Stereotactic radiosurgery (SRS) method has been considered the first-line treatment option to treat patients involved with pre-optic nerve tumors. However, studies have shown that using fractionated SRS, normal tissue sparing and tumor dose can be strongly increased simultaneously. Our main goal was to illustrate the effects of fractionated SRS approach in optic nerve tumor treatment and its adjacent sensitive structures. Materials and methods: 19 patients involved in optic nerve tumor with clinical symptoms of vision loss were treated with Gamma Knife radiosurgery in three sessions with 12 hours intervals between them. The prescribed dose was about 6.0 ± 1.2 Gy. Patient-related parameters including pre-treatment and after-treatment tumor size, visual acuity and visual field were evaluated using the Snell chart and MRI imaging. Patients were followed for about 14 months. Result: The overall result showed vision improvement for patients with low and moderate visual loss. However, there was no significant improvement in patients with severe visual loss. Relative improvement was observed in blind patients, although poorly. There was no evidence of growth, recurrence, or new tumor after treatment in patients. Conclusion: Fractionated gamma knife radiosurgery offers a safe and effective alternative for benign lesions adjacent to the optic nerve. [ABSTRACT FROM AUTHOR] |
Databáze: |
Supplemental Index |
Externí odkaz: |
|